Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Synthesis and biological activity of A-nor-paclitaxel analogues.
Chordia MD, Kingston DG, Hamel E, Lin CM, Long BH, Fairchild CA, Johnston KA, Rose WC. Chordia MD, et al. Among authors: johnston ka. Bioorg Med Chem. 1997 May;5(5):941-7. doi: 10.1016/s0968-0896(97)00035-7. Bioorg Med Chem. 1997. PMID: 9208103
Synthesis and biological evaluation of 2-acyl analogues of paclitaxel (Taxol).
Kingston DG, Chaudhary AG, Chordia MD, Gharpure M, Gunatilaka AA, Higgs PI, Rimoldi JM, Samala L, Jagtap PG, Giannakakou P, Jiang YQ, Lin CM, Hamel E, Long BH, Fairchild CR, Johnston KA. Kingston DG, et al. Among authors: johnston ka. J Med Chem. 1998 Sep 10;41(19):3715-26. doi: 10.1021/jm980229d. J Med Chem. 1998. PMID: 9733497
Synthesis and bioactivity of 2,4-diacyl analogues of paclitaxel.
Chordia MD, Yuan H, Jagtap PG, Kadow JF, Long BH, Fairchild CR, Johnston KA, Kingston DG. Chordia MD, et al. Among authors: johnston ka. Bioorg Med Chem. 2001 Jan;9(1):171-8. doi: 10.1016/s0968-0896(00)00233-9. Bioorg Med Chem. 2001. PMID: 11197337
Synthesis of metabolically blocked paclitaxel analogues.
Wittman MD, Altstadt TJ, Fairchild C, Hansel S, Johnston K, Kadow JF, Long BH, Rose WC, Vyas DM, Wu MJ, Zoeckler ME. Wittman MD, et al. Bioorg Med Chem Lett. 2001 Mar 26;11(6):809-10. doi: 10.1016/s0960-894x(01)00066-x. Bioorg Med Chem Lett. 2001. PMID: 11277525
Synthesis and Biological Evaluation of 1-Deoxypaclitaxel Analogues.
Kingston DG, Chordia MD, Jagtap PG, Liang J, Shen YC, Long BH, Fairchild CR, Johnston KA. Kingston DG, et al. Among authors: johnston ka. J Org Chem. 1999 Mar 19;64(6):1814-1822. doi: 10.1021/jo981406l. J Org Chem. 1999. PMID: 11674269
Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.
Lombardo LJ, Lee FY, Chen P, Norris D, Barrish JC, Behnia K, Castaneda S, Cornelius LA, Das J, Doweyko AM, Fairchild C, Hunt JT, Inigo I, Johnston K, Kamath A, Kan D, Klei H, Marathe P, Pang S, Peterson R, Pitt S, Schieven GL, Schmidt RJ, Tokarski J, Wen ML, Wityak J, Borzilleri RM. Lombardo LJ, et al. J Med Chem. 2004 Dec 30;47(27):6658-61. doi: 10.1021/jm049486a. J Med Chem. 2004. PMID: 15615512
Preclinical efficacy spectrum and pharmacokinetics of ixabepilone.
Lee FY, Smykla R, Johnston K, Menard K, McGlinchey K, Peterson RW, Wiebesiek A, Vite G, Fairchild CR, Kramer R. Lee FY, et al. Cancer Chemother Pharmacol. 2009 Jan;63(2):201-12. doi: 10.1007/s00280-008-0727-5. Epub 2008 Mar 19. Cancer Chemother Pharmacol. 2009. PMID: 18350296
79 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page